Efficacy and safety of a sodium‐glucose co‐transporter‐2 inhibitor versus placebo as an add‐on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase‐4 inhibitor: a systematic review and meta‐analysis of randomised controlled trials
Distribution of the number of citations over years.